Physician profile
Sharanya Joginpalli
NPI 1679067441
$815.60
in general payments reported to CMS, 2019-2025
19 companies · $741 in 2025
The $741 reported for 2025 was more than what 80% of Pediatric Rheumatology providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $74.48 · 2025: $741.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $816.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $815.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $112.49 | 2025 | Briviact, Fintepla |
| Sk Life Science, INC. | $86.48 | 2025 | |
| Novartis Pharmaceuticals Corporation | $73.21 | 2024-2025 | |
| Glaxosmithkline, LLC. | $65.64 | 2025 | Benlysta |
| Vertical Pharmaceuticals, LLC | $59.97 | 2024-2025 | Relexxii |
| Noven Therapeutics, LLC | $42.56 | 2025 | Xelstrym |
| Tris Pharma INC | $40.38 | 2025 | Dyanavel Xr |
| Octapharma USA, INC. | $35.76 | 2025 | Panzyga |
| Csl Behring | $34.73 | 2025 | Hizentra |
| Mallinckrodt Hospital Products INC. | $34.57 | 2025 | Acthar |
| Upsher-Smith Laboratories LLC | $34.12 | 2025 | |
| Jazz Pharmaceuticals INC. | $32.17 | 2025 | |
| Pfizer INC. | $31.81 | 2025 | |
| Biogen, INC. | $28.96 | 2025 | Skyclarys |
| Corium, LLC | $27.87 | 2024 | Azstarys |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $25.46 | 2025 | |
| Neos Therapeutics, Lp | $17.50 | 2025 | Cotempla Xr-Odt |
| Neurelis, INC. | $16.39 | 2025 | Valtoco |
| Alexion Pharmaceuticals, INC. | $15.53 | 2025 | Strensiq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharanya Joginpalli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.